Zhejiang Haisen Pharmaceutical Co., Ltd. (SHE:001367)
China
· Delayed Price · Currency is CNY 23.01
-0.04 (-0.17%)
Mar 9, 2026, 4:00 PM EDT
SHE:001367 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Net Income | 123.82 | 122.56 | 104.67 | 107.59 | 94 | 62.83 | Upgrade
|
| Depreciation & Amortization | 16.51 | 16.51 | 13.41 | 14.3 | 13.03 | 10.64 | Upgrade
|
| Other Amortization | 0.78 | 0.78 | 1.99 | 1.68 | 1.71 | 0.99 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | 0.24 | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 1.23 | 1.23 | 0.96 | 1.21 | 0.67 | 0.24 | Upgrade
|
| Loss (Gain) From Sale of Investments | -3 | -3 | -0.32 | 3.85 | -1.45 | -3.59 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.09 | 0.09 | 0.43 | 1.09 | -0.27 | -0.64 | Upgrade
|
| Other Operating Activities | -14.03 | 0.6 | 1.6 | -7.45 | 4.29 | 4.42 | Upgrade
|
| Change in Accounts Receivable | -27.23 | -27.23 | -20.56 | 11.11 | -22.35 | 10.7 | Upgrade
|
| Change in Inventory | 37.64 | 37.64 | -19.1 | -38.88 | -20.63 | -18.4 | Upgrade
|
| Change in Accounts Payable | 11.19 | 11.19 | -4.6 | -19.29 | 36.22 | 8.25 | Upgrade
|
| Change in Other Net Operating Assets | 5.77 | 5.77 | -0.08 | 0.22 | -0.24 | 0.53 | Upgrade
|
| Operating Cash Flow | 153.79 | 167.16 | 80.62 | 74.95 | 107.04 | 76.49 | Upgrade
|
| Operating Cash Flow Growth | -5.81% | 107.35% | 7.56% | -29.98% | 39.93% | 63.07% | Upgrade
|
| Capital Expenditures | -151.13 | -64.75 | -57.44 | -20.19 | -33.32 | -21.02 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0.12 | - | 0 | - | Upgrade
|
| Investment in Securities | -234.34 | 3 | 0.32 | -0.99 | -1.21 | 48.84 | Upgrade
|
| Investing Cash Flow | -385.65 | -61.75 | -57 | -21.18 | -34.52 | 27.83 | Upgrade
|
| Long-Term Debt Repaid | - | -1.86 | -1.04 | -1.15 | -0.88 | - | Upgrade
|
| Total Debt Repaid | -1.86 | -1.86 | -1.04 | -1.15 | -0.88 | - | Upgrade
|
| Net Debt Issued (Repaid) | -1.86 | -1.86 | -1.04 | -1.15 | -0.88 | - | Upgrade
|
| Issuance of Common Stock | 29.05 | 25.46 | 698.45 | - | - | - | Upgrade
|
| Common Dividends Paid | -18.34 | -34 | - | -0.71 | -16.43 | -53.89 | Upgrade
|
| Other Financing Activities | 0.02 | - | -24.08 | -1.9 | -1.4 | - | Upgrade
|
| Financing Cash Flow | 8.87 | -10.39 | 673.33 | -3.77 | -18.71 | -53.89 | Upgrade
|
| Foreign Exchange Rate Adjustments | 2.19 | 2.68 | 0.61 | 5.52 | -1.46 | -1.97 | Upgrade
|
| Net Cash Flow | -220.8 | 97.69 | 697.55 | 55.52 | 52.35 | 48.46 | Upgrade
|
| Free Cash Flow | 2.66 | 102.41 | 23.17 | 54.76 | 73.72 | 55.48 | Upgrade
|
| Free Cash Flow Growth | -96.92% | 341.91% | -57.68% | -25.73% | 32.89% | 91.61% | Upgrade
|
| Free Cash Flow Margin | 0.52% | 21.72% | 5.83% | 12.95% | 18.95% | 19.48% | Upgrade
|
| Free Cash Flow Per Share | 0.02 | 0.68 | 0.17 | 0.49 | 0.66 | 0.50 | Upgrade
|
| Cash Income Tax Paid | 18.42 | 19.27 | 33.38 | 5.24 | 12.89 | 9.94 | Upgrade
|
| Levered Free Cash Flow | 3.21 | 84.18 | -18.14 | -2.35 | 44.27 | 31.09 | Upgrade
|
| Unlevered Free Cash Flow | 3.43 | 84.41 | -18.12 | -2.31 | 44.34 | 31.09 | Upgrade
|
| Change in Working Capital | 28.39 | 28.39 | -42.36 | -47.31 | -4.94 | 1.61 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.